Importance of IgG2c isotype in the immune response to β-amyloid in amyloid precursor protein/transgenic mice

被引:52
作者
Petrushina, I
Tran, M
Sadzikava, N
Ghochikyan, A
Vasilevko, V
Agadjanyan, MG
Cribbs, DH
机构
[1] Inst Mol Med, Dept Immunol, Huntington Beach, CA 92649 USA
[2] Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA
关键词
amyloid precursor protein/transgenic mice; IgG2a and IgG2c genes; Ig isotypes; A beta(42); TRANSGENIC MOUSE MODELS; DISEASE-LIKE PATHOLOGY; ALZHEIMERS-DISEASE; ANTIBODIES; PEPTIDE; PROTEIN;
D O I
10.1016/S0304-3940(02)01357-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A careful analysis of the immune response to immunization of amyloid precursor protein/transgenic (APP/Tg) mice with beta-amyloid (Abeta) may provide insights into why a subset of the patients in a clinical trial receiving Abeta-immunotherapy developed encephalomyelitis. Characterization of isotypic immune responses have been reported in different APP/Tg models. In these studies the relative ratios of IgG1 to IgG2a anti-Abeta antibodies has been used as an indirect measure of T helper 1 (Th1) and Th2 types immune responses. However, it has previously been shown that certain strains of mice, C57B1/6, C57B1/10, SJL, and NOD, have an IgG2c rather than an IgG2a gene. Since a substantial number of Abeta-immunization studies rely on APP/Tg mice that have at least one parental C57B1/6 strain, we have investigated whether antibodies specific for IgG2a can be used for characterization of antibody isotypes in APP/Tg2576 mice. Our results suggest that APP/Tg2576 and major histocompatibilty complex-matched parental strains are not expressing IgG2a, producing instead IgG2c anti-Abeta antibodies. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:5 / 8
页数:4
相关论文
共 17 条
[1]   Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].
Bard, F ;
Cannon, C ;
Barbour, R ;
Burke, RL ;
Games, D ;
Grajeda, H ;
Guido, T ;
Hu, K ;
Huang, JP ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, M ;
Lieberburg, I ;
Motter, R ;
Nguyen, M ;
Soriano, F ;
Vasquez, N ;
Weiss, K ;
Welch, B ;
Seubert, P ;
Schenk, D ;
Yednock, T .
NATURE MEDICINE, 2000, 6 (08) :916-919
[2]   Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins [J].
Borchelt, DR ;
Ratovitski, T ;
vanLare, J ;
Lee, MK ;
Gonzales, V ;
Jenkins, NA ;
Copeland, NG ;
Price, DL ;
Sisodia, SS .
NEURON, 1997, 19 (04) :939-945
[3]   Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease [J].
DeMattos, RB ;
Bales, KR ;
Cummins, DJ ;
Dodart, JC ;
Paul, SM ;
Holtzman, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) :8850-8855
[4]   Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated β-amyloid 1-42 peptide [J].
Dickey, CA ;
Morgan, DG ;
Kudchodkar, S ;
Weiner, DB ;
Bai, Y ;
Cao, CH ;
Gordon, MN ;
Ugen, KE .
DNA AND CELL BIOLOGY, 2001, 20 (11) :723-729
[5]   LYMPHOKINE CONTROL OF INVIVO IMMUNOGLOBULIN ISOTYPE SELECTION [J].
FINKELMAN, FD ;
HOLMES, J ;
KATONA, IM ;
URBAN, JF ;
BECKMANN, MP ;
PARK, LS ;
SCHOOLEY, KA ;
COFFMAN, RL ;
MOSMANN, TR ;
PAUL, WE .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :303-333
[6]   ALZHEIMER-TYPE NEUROPATHOLOGY IN TRANSGENIC MICE OVEREXPRESSING V717F BETA-AMYLOID PRECURSOR PROTEIN [J].
GAMES, D ;
ADAMS, D ;
ALESSANDRINI, R ;
BARBOUR, R ;
BERTHELETTE, P ;
BLACKWELL, C ;
CARR, T ;
CLEMENS, J ;
DONALDSON, T ;
GILLESPIE, F ;
GUIDO, T ;
HAGOPIAN, S ;
JOHNSONWOOD, K ;
KHAN, K ;
LEE, M ;
LEIBOWITZ, P ;
LIEBERBURG, I ;
LITTLE, S ;
MASLIAH, E ;
MCCONLOGUE, L ;
MONTOYAZAVALA, M ;
MUCKE, L ;
PAGANINI, L ;
PENNIMAN, E ;
POWER, M ;
SCHENK, D ;
SEUBERT, P ;
SNYDER, B ;
SORIANO, F ;
TAN, H ;
VITALE, J ;
WADSWORTH, S ;
WOLOZIN, B ;
ZHAO, J .
NATURE, 1995, 373 (6514) :523-527
[7]   Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice [J].
Hsiao, K ;
Chapman, P ;
Nilsen, S ;
Eckman, C ;
Harigaya, Y ;
Younkin, S ;
Yang, FS ;
Cole, G .
SCIENCE, 1996, 274 (5284) :99-102
[8]   Transgenic mouse models of Alzheimer's disease [J].
Janus, C ;
Chishti, MA ;
Westaway, D .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01) :63-75
[9]   THE MOUSE IGH-1A AND IGH-1B H-CHAIN CONSTANT REGIONS ARE DERIVED FROM 2 DISTINCT ISOTYPIC GENES [J].
JOUVINMARCHE, E ;
MORGADO, MG ;
LEGUERN, C ;
VOEGTLE, D ;
BONHOMME, F ;
CAZENAVE, PA .
IMMUNOGENETICS, 1989, 29 (02) :92-97
[10]   Nasal vaccination with β-amyloid peptide for the treatment of Alzheimer's disease [J].
Lemere, CA ;
Maron, R ;
Selkoe, DJ ;
Weiner, HL .
DNA AND CELL BIOLOGY, 2001, 20 (11) :705-711